E-LIB Suche - Ergebnisse für: Ertl, Hildegund C.J.

1

Treatment with the PPARα agonist fenofibrate improves the e..:

Hasanpourghadi, Mohadeseh ; Chekaoui, Arezki ; Kurian, Sophia...
Molecular Therapy - Oncolytics. 31 (2023) - p. 100744 , 2023

Link: https://doi.org/10.1016/..

2

Mitigating Serious Adverse Events in Gene Therapy with AAV ..:

Ertl, Hildegund C. J.
Drugs. 83 (2023) 4 - p. 287-298 , 2023

Link: https://doi.org/10.1007/..

3

Intranasal multivalent adenoviral-vectored vaccine protects..:

Afkhami, Sam ; D'Agostino, Michael R. ; Vaseghi-Shanjani, Maryam...
npj Vaccines. 8 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

Historical Progression from Nerve Tissue-Based Rabies Vacci..:

, In: History of Rabies in the Americas: From the Pre-Columbian to the Present, Volume I; Fascinating Life Sciences,

Ertl, Hildegund C. J. - p. 121-142 , 2023

Link: https://doi.org/10.1007/..

5

2320. Novel checkpoint modifier lowers T cell activation th..:

Hasanpourghadi, Mohadeseh ; Luber, Andrew ; Currie, Sue...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

6

PD-1 directed immunotherapy alters Tfh and humoral immune r..:

Herati, Ramin Sedaghat ; Knorr, David A. ; Vella, Laura A....
Nature Immunology. 23 (2022) 8 - p. 1183-1192 , 2022

Link: https://doi.org/10.1038/..

7

Back to the Future: Can Vaccines Win the Long-Term Fight Ag..:

Ertl, Hildegund C. J. ; Currie, Sue L. ; Livermore, David M.
Frontiers in Public Health. 10 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

8

Safety and immunogenicity of a simian-adenovirus-vectored r..:

Jenkin, Daniel ; Ritchie, Adam J ; Aboagye, Jeremy...
The Lancet Microbe. 3 (2022) 9 - p. e663-e671 , 2022

Link: https://doi.org/10.1016/..

9

A One Medicine Mission for an Effective Rabies Therapy:

Knobel, Darryn L. ; Jackson, Alan C. ; Bingham, John...
Frontiers in Veterinary Science. 9 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

10

Immunogenicity and toxicity of AAV gene therapy:

Ertl, Hildegund C. J.
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

11

Restricting use of adenovirus vector-based COVID vaccines c..:

Ertl, Hildegund C. J. ; Currie, Sue L. ; Luber, Andrew D.
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

12

COVID-19 Vaccines Based on Adenovirus Vectors:

Hasanpourghadi, Mohadeseh ; Novikov, Mikhail ; Ertl, Hildegund C.J.
Trends in Biochemical Sciences. 46 (2021) 5 - p. 429-430 , 2021

Link: https://doi.org/10.1016/..

13

T Cell-Mediated Immune Responses to AAV and AAV Vectors:

Ertl, Hildegund C. J.
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

14

Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive bi..:

Herati, Ramin Sedaghat ; Silva, Luisa Victoria ; Vella, Laura A....
Cell Reports Medicine. 2 (2021) 5 - p. 100262 , 2021

Link: https://doi.org/10.1016/..

15

Hepatitis B virus polymerase-specific T cell epitopes shift..:

Hasanpourghadi, Mohadeseh ; Novikov, Mikhail ; Newman, Dakota...
Virology Journal. 18 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..